欧洲和中国心脏调查预后和潜在的治疗意义-英文课件精选.pptVIP

Prescribed glucose lowering drugs 77 (17%) 1% 16% 1% 83% Insulin Oral drugs Combinations No prescription Newly detected diabetes n = 452 Not prescribed glucose lowering drugs 375 (83%) Glycemic control Experiences from the Euro Heart Survey Glucose lowering drugs at follow up in patients with newly detected diabetes (Anselmino et al; Europ Heart J 2008; 29:177) 1 1 0,90 0,92 0,94 0,96 0,98 1,00 Log rank test p=0.047 Yes No 0 100 200 300 400 Cumulative event free rate Time of follow up (days) Glucose lowering drug Euro Heart Survey diabetes and the heart Impact of glucose lowering drugs